logo image
search icon
Alopecia Market

Alopecia Market Size, Share & Trends Analysis Report Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Androgenetic Alopecia, Alopecia Totalis, Alopecia Universalis), By Treatment (Pharmaceutical, Devices), By Gender (Male, Female), By Sales Channel (Prescriptions, OTC), By End-use, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2892 | Published : 2024-11-13 | Pages: 172 | Format: PDF/EXCEL

The Alopecia Market Size is valued at USD 8.6 billion in 2023 and is predicted to reach USD 17.8 billion by the year 2031 at a 9.8% CAGR during the forecast period for 2024-2031.

alopecia Market

Alopecia is an autoimmune disease that damages hair follicles and causes hair loss. The commercial landscape for medicines and treatments targeting this condition is included in the worldwide Alopecia Market. Hence, the rising cases of chronic diseases related to hair loss are expected to increase the alopecia market in the near future. The growing prevalence of hair loss and advancement in technology are factors expected to drive the growth of the global Alopecia market. Rising healthcare expenses, growing disposable income, and increasing emphasis on aesthetic appearance are some of the other factors expected to boost the market expansion in the coming years.

However, the high cost of Alopecia, negative effects of hair loss treatments, and the COVID-19 pandemic may hinder target market expansion throughout the foreseeable year. Over the forecast period, rising R&D, government initiatives to use sustainable materials, and major player investments are expected to create lucrative revenue growth opportunities for global Alopecia market players.

Competitive Landscape

Some Major Key Players In The Alopecia Market:

  • Janssen Global Services Inc.
  • Cipla Limited
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Sun Pharmaceuticals Industries Ltd
  • Dr Reddy's Laboratories Ltd
  • Aurobindo Pharma
  • Viatris Inc.
  • Pfizer, Inc.
  • Eli Lilly
  • Lexington Intl., LLC
  • Freedom Laser Therapy
  • Curallux, LLC
  • Apira Sciences Inc.
  • Revian Inc.
  • Theradome
  • Lutronic
  • iRestore Hair Growth System
  • iGrow Laser
  • Theradome
  • Other Market Players

Market Segmentation:

The Alopecia market is segmented on the basis of disease type, treatment, gender, sales channel, and end use. Based on disease type, the market is segmented as alopecia areata, cicatrical Alopecia, traction alopecia, alopecia totalis, alopecia universalis, androgenetic Alopecia, and others. By treatment, the market is segmented into pharmaceuticals and devices. The gender segment consists of male and female. As per the sales channel, the market is segmented into prescriptions and OTC. By end use, the market is segmented into homecare settings and dermatology clinics.

Based On Disease Type, The Alopecia Areata Segment Accounts For A Major Contributor To The Alopecia Market.

The alopecia areata category is expected to hold a major share of the global Alopecia market in 2023. This is attributed to growing consumer awareness about the disease. According to the National Alopecia Areata Foundation, about 147 million people globally are affected by Alopecia. Additionally, the growing development of novel therapy and favorable advantages in the process of approval are anticipated to increase market growth.

The Male Segment Witnessed Growth At A Rapid Rate.

The male segment is estimated to grow at a rapid rate in the global Alopecia market owing to the increasing prevalence of hair loss in the male population globally. Hence, with the growing tobacco intake in men and an increasing aged population, there is an increase in demand for Alopecia in the healthcare hair loss sector.

In The Region, The North American Alopecia Market Holds A Significant Revenue Share.

The North American alopecia market is expected to report the prominent market share in terms of revenue in the near future. This can be attributed to the strong focus on hair loss disease in the region, with the increasing adoption of Alopecia. In addition, increasing adoption of laser-based therapy for treatment and rising consumer awareness is anticipated to increase the market growth. Government and non-profit organizations' initiatives to create consumer awareness in the region are factors increasing the growth of the target market. The Asia Pacific is esetimated to grow with at a rapid rate in the global Alopecia market due to growing demand for effective treatment options, government initiatives, increasing funding in various industries.

Recent Developments:

  • In July 2024, Sun Pharmaceutical Industries Ltd has announced that its LEQSELVI (deuruxolitinib) drug has been approved by the US health regulatory agency to treat severe alopecia areata in adults. Sun Pharma disclosed in a regulatory filing that the USFDA has granted approval for LEQSELVI (deuruxolitinib) 8 mg tablets.
  • In July 2023, REVIAN Inc. released that the Revian Red Hair Growth System is anticipated to be in the second study. It is projected as an effective treatment option for Central Centrifugal Cicatricial Alopecia.

Alopecia Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 8.6 Bn

Revenue Forecast In 2031

USD 17.8 Bn

Growth Rate CAGR

CAGR of 9.8% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Disease Type, Treatment, Gender, Sales Channel, And End Use

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea

Competitive Landscape

Janssen Global Services Inc., Cipla Limited, Merck & Co., Inc., GlaxoSmithKline Plc, Sun Pharmaceuticals Industries Ltd, Dr. Reddy’s Laboratories Ltd, Aurobindo Pharma, Viatris Inc., Pfizer, Inc., Lilly, Lexington Intl., LLC, Freedom Laser Therapy, Curallux, LLC, Apira Science Inc., Revian Inc., Theradome, and Lutronic.

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1.       Methodology and Scope

1.1.      Research Methodology

1.2.      Research Scope & Assumptions

Chapter 2.       Executive Summary

Chapter 3.       Global Alopecia Market Snapshot

Chapter 4.       Global Alopecia Market Variables, Trends & Scope

4.1.      Market Segmentation & Scope

4.2.      Drivers

4.3.      Challenges

4.4.      Trends

4.5.      Investment and Funding Analysis

4.6.      Porter's Five Forces Analysis

4.7.      Incremental Opportunity Analysis (US$ MN), 2024-2031

4.8.      Global Alopecia Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031

4.9.      Competitive Landscape & Market Share Analysis, By Key Player (2023)

4.10.    Use/impact of AI on Alopecia Industry Trends

Chapter 5.       Alopecia Market Segmentation 1: By Disease Type, Estimates & Trend Analysis

5.1.      Market Share by Disease Type, 2023 & 2031

5.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Type

5.2.1.   Alopecia Areata

5.2.2.   Cicatricial Alopecia

5.2.3.   Traction Alopecia

5.2.4.   Alopecia Totalis

5.2.5.   Alopecia Universalis

5.2.6.   Androgenetic Alopecia

5.2.7.   Others

Chapter 6.       Alopecia Market Segmentation 2: By Treatment, Estimates & Trend Analysis

6.1.      Market Share by Treatment, 2023 & 2031

6.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Treatments:

6.2.1.   Pharmaceuticals

6.2.1.1.            Topical

6.2.1.1.1.         OTC

6.2.1.1.1.1.      Minoxidil

6.2.1.1.1.2.      Others

6.2.1.1.2.         Prescription

6.2.1.1.2.1.      Betamethasone Dipropionate

6.2.1.1.2.2.      Fluocinolone Acetonide

6.2.1.1.2.3.      Finasteride

6.2.1.1.2.4.      Minoxidil

6.2.1.2.            Oral

6.2.1.2.1.         OTC

6.2.1.2.1.1         Prescription

6.2.1.2.1.1.      Minoxidil

6.2.1.2.1.2.      Finasteride

6.2.1.2.1.3.      Corticosteroids

6.2.1.2.1.4.      Others (JAK inhibitors and others)

6.2.1.2.2.            PRP

6.2.2.   Devices

6.2.2.1.            Laser Cap

6.2.2.2.            Laser Comb

6.2.2.3.            Laser Helmet

Chapter 7.       Alopecia Market Segmentation 3: By Gender, Estimates & Trend Analysis

7.1.      Market Share by Gender, 2023 & 2031

7.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Gender:

7.2.1.   Male

7.2.2.   Female

Chapter 8.       Alopecia Market Segmentation 4: By Sales Channel, Estimates & Trend Analysis

8.1.      Market Share by Sales Channel, 2023 & 2031

8.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Sales Channel:

8.2.1.   Prescriptions

8.2.2.   OTC

Chapter 9.       Alopecia Market Segmentation 5: By End User, Estimates & Trend Analysis

9.1.      Market Share by End User, 2023 & 2031

9.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End User:

9.2.1.   Homecare Settings

9.2.2.   Dermatology Clinics

Chapter 10.     Alopecia Market Segmentation 6: Regional Estimates & Trend Analysis

10.1.    Global Alopecia Market, Regional Snapshot 2023 & 2031

10.2.    North America

10.2.1. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

10.2.1.1.          US

10.2.1.2.          Canada

10.2.2. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031

10.2.3. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031

10.2.4. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031

10.2.5. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031

10.2.6. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031

10.3.    Europe

10.3.1. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

10.3.1.1.          Germany

10.3.1.2.          U.K.

10.3.1.3.          France

10.3.1.4.          Italy

10.3.1.5.          Spain

10.3.1.6.          Rest of Europe

10.3.2. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031

10.3.3. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031

10.3.4. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031

10.3.5. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031

10.3.6. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031

10.4.    Asia Pacific

10.4.1. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

10.4.1.1.          India

10.4.1.2.          China

10.4.1.3.          Japan

10.4.1.4.          Australia

10.4.1.5.          South Korea

10.4.1.6.          Hong Kong

10.4.1.7.          Southeast Asia

10.4.1.8.          Rest of Asia Pacific

10.4.2. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031

10.4.3. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031

10.4.4. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031

10.4.5. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts By Sales Channel, 2024-2031

10.4.6. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031

10.5.    Latin America

10.5.1. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

10.5.1.1.          Brazil

10.5.1.2.          Mexico

10.5.1.3.          Rest of Latin America

10.5.2. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031

10.5.3. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031

10.5.4. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031

10.5.5. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031

10.5.6. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031

10.6.    Middle East & Africa

10.6.1. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.6.1.1.          GCC Countries

10.6.1.2.          Israel

10.6.1.3.          South Africa

10.6.1.4.          Rest of Middle East and Africa

10.6.2. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031

10.6.3. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031

10.6.4. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031

10.6.5. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031

10.6.6. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031

Chapter 11.     Competitive Landscape

11.1.    Major Mergers and Acquisitions/Strategic Alliances

11.2.    Company Profiles

 

11.2.1. Janssen Global Services Inc.

11.2.1.1.          Business Overview

11.2.1.2.          Key Product/Service Offerings

11.2.1.3.          Financial Performance

11.2.1.4.          Geographical Presence

11.2.1.5.          Recent Developments with Business Strategy

11.2.2. Cipla Limited

11.2.3. Merck & Co., Inc.

11.2.4. GlaxoSmithKline Plc

11.2.5. Sun Pharmaceuticals Industries Ltd

11.2.6. Dr Reddy's Laboratories Ltd

11.2.7. Aurobindo Pharma

11.2.8. Viatris Inc.

11.2.9. Pfizer, Inc.

11.2.10.           Eli Lilly

11.2.11.           Lexington Intl., LLC

11.2.12.           Freedom Laser Therapy

11.2.13.           Curallux, LLC

11.2.14.           Apira Sciences Inc.

11.2.15.           Revian Inc.

11.2.16.           Theradome

11.2.17.           Lutronic

11.2.18.           iRestore Hair Growth System

11.2.19.           iGrow Laser

11.2.20.           Theradome

11.2.21.           Other Prominent Players

Segmentation of Alopecia Market-

Alopecia Market By Disease Type-

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Androgenetic Alopecia
  • Others

alopecia market

Alopecia Market By Treatment-

  • Pharmaceuticals
    • Topical
      • OTC
        • Minoxidil
        • Others
      • Prescription
        • Betamethasone Dipropionate
        • Fluocinolone Acetonide
        • Finasteride
        • Minoxidil
      • Oral
        • OTC
          • Prescription
          • Minoxidil
          • Finasteride
          • Corticosteroids
          • Others (JAK inhibitors and others)
        • PRP 
      • Devices
        • Laser Cap
        • Laser Comb
        • Laser Helmet

Alopecia Market By Gender-

  • Male
  • Female

Alopecia Market By Sales Channel-

  • Prescriptions
  • OTC

Alopecia Market By End Use-

  • Homecare Settings
  • Dermatology Clinics

Alopecia Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Alopecia Market Size?

The Alopecia Market is expected to grow at a 9.8% CAGR during the forecast period for 2024-2031.

Janssen Global Services Inc., Cipla Limited, Merck & Co., Inc., GlaxoSmithKline Plc, Sun Pharmaceuticals Industries Ltd, Dr. Reddy’s Laboratories Ltd,

Disease Type, Treatment, Gender, Sales Channel, And End Use are the key segments of the Alopecia Market.

North American region is leading the Alopecia Market.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach